Free Trial

BTIG Research's Rating of Exagen on 8/5/2026

On August 5, 2026, BTIG Research updated its outlook on Exagen (NASDAQ:XGN) with the action "Boost Price Target", setting a price target of $9.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from BTIG Research

DateCompanyAction
10/16/2026
Twilio Inc. stock logo
TWLO
Twilio
Boost Price Target
10/16/2026
Workday, Inc. stock logo
WDAY
Workday
Reiterated Rating
10/16/2026
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
Reiterated Rating
10/16/2026
Prologis, Inc. stock logo
PLD
Prologis
Reiterated Rating
10/15/2026
Verastem, Inc. stock logo
VSTM
Verastem
Boost Price Target
10/15/2026
Core Scientific, Inc. stock logo
CORZ
Core Scientific
Reiterated Rating
More Ratings From BTIG Research